IFPMA in Brief

IFPMA in Brief

IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.

Our Resources


There are many challenges in improving public health policy for current and future generations. To play an effective role in advancing these policies, the research-based biopharmaceutical industry needs an informed and credible voice in the conversation with the global health community. That voice is IFPMA.


Our Blog

Latest Tweets

.@worldheartfed launches global call for better surveillance systems to put a halt to premature deaths from #CVD https://t.co/sctyX1CFAQ
2 2
RT @WHO: The new Global Hearts Initiative can save millions of lives. Cardiovascular diseases are the no. 1 killer worldwide #BeatNCDs #UNG…
RT @CDCGlobal: #beatNCDs: @abcDrBchat, @WHO Margaret Chan, John Boyce, Barbados MoH, @MikeBloomberg & @DrFriedenCDC at Global Hearts Ini…
IFPMA DG Eduardo Pisani speaks about industry commitments to tackle #antimicrobialresistance https://t.co/hjT0iqLSHi via @OECD
With 4 commitments to keep existing #antibiotics effective & promote innovation, see new roadmap to combat #AMR https://t.co/lzxH6YCE4T